Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
US-9757355-B2 · Sep 12, 2017 · US
Hui Ho-Wah was listed as an assignee on 1 patent publication in 2017.
| Metric | Value |
|---|---|
| Company | Hui Ho-Wah |
| Year | 2017 |
| Patents | 1 |
Representative publications for Hui Ho-Wah in 2017.
Most common classification codes for Hui Ho-Wah in 2017.
| CPC | Patents |
|---|---|
| A61K31/4035 | 1 |
| A61K9/1617 | 1 |
| A61K9/1635 | 1 |
| A61K9/1652 | 1 |
| A61K9/4825 | 1 |
Navigate to parent entity pages.